Chronic Obstructive Pulmonary Disease Diagnosis
Chronic Obstructive Pulmonary Diagnosis : Typical symptoms and diagnosis of Chronic Obstructive Pulmonary Disease are cough, phlegm, and chronic and progressive dyspnea. Chronic cough and phlegm may appear earlier than the obstruction of exhaled airflow. People with these symptoms, especially in high-risk groups, are advised to have spirometry in the thoracic medicine, and receive appropriate treatment.
Chronic Obstructive Pulmonary Diagnosis : Diagnosis should confirm the presence of dyspnoea, chronic cough, phlegm, risk factor, history of exposure, and lung measurement as a diagnostic tool. Diagnosis should not be based solely on detection of lung function, chest X-ray, chest computerized tomography.
Global Initiative for Chronic Obstructive Lung Disease (GOLD) guide in integrated stated there were some limitations on pulmonary function in ABCD evaluation. The pulmonary function is assessed independently, and the severity of symptoms and the number of occurrences of the patient is the same as ABCD four ethnic groups.
The main cause of COPD is smoking, which in some countries is manifested by long-term exposure to sources of pollution from indoor fires. Chronic obstructive pulmonary disease (COPD) lurks for many years. Genes also increase the risk of chronic obstructive pulmonary disease.
Globally, the leading culprit for COPD is smoking. About 20 per cent of smokers have a high risk of COPD, while half of those lifelong smokers will suffer from COPD. In the United States and the United Kingdom, 80 to 95 percent of COPD patients are smokers. They are either smoking, or have been smoking. Long-term exposure to smoke increases the likelihood of chronic obstructive pulmonary disease. It is important to note that women are more vulnerable than men to the dangers of smoking. Chronic obstructive pulmonary disease (COPD) is 20 per cent of non-smokers who suffer from COPD. Other types of smoking, like marijuana, cigars and hookah, are also an incentive. Smoking in pregnant women may also increase the risk of chronic obstructive pulmonary disease in infants.
Treatment for Chronic Obstructive Pulmonary
Chronic obstructive pulmonary disease (COPD) is still intractable and can only be relieved by improving the living environment and medication.
Patients with chronic obstructive pulmonary disease cannot inhale high concentrations of oxygen. Maintain oxygen inhalation at about 1-2L/min and blood oxygen content at 88-92% is acceptable.
The main goal of treatment for patients with stable pulmonary obstruction can be to improve symptoms and reduce risk. To improve symptoms, mainly to relieve symptoms, improve exercise tolerance, improve quality of life and health; to reduce risk, mainly to prevent disease progression, prevent acute deterioration and reduce mortality.
According to the 2020 Global Initiative for Chronic Obstructive Pulmonary Disease (COPD) guidelines, patients with pulmonary obstruction can be classified into A, B, C, and D according to their group. Depending on the patient’s response to the drug, including improvement of symptoms and the risk of acute deterioration, the treatment will be determined. Upgraded drug treatment strategies are based on current clinical evidence of drug efficacy and safety, which may be revised in the future.
Quitting smoking and avoiding exposure to second-hand smoke can prevent the vast majority of COPD cases. Kitchen smoke, incense smoke, can also reduce lung function.
In high dust sites, such as mines, employers must improve tools for workers to reduce dust inhalation and regularly check workers’ lung function.
The stronger the willingness of the society as a whole to control air pollution, the less the incidence.
It is better to prevent this than to go through the Chronic Obstructive Pulmonary Disease Diagnosis.